Uterine Artery Embolization for Fibroid Treatment

A new minimally invasive treatment for symptomatic uterine fibroids uses uterine artery embolization (UAE) to block blood flow to the vessels feeding a fibroid, thereby reducing the associated symptoms. The treatment is now in a multicenter clinical trial.

The standard surgical therapy for fibroids has been hysterectomy and myomectomy. Successful completion of the clinical trial may demonstrate that UAE offers women an effective alternative to surgery for fibroid treatment. The trial is designed to evaluate the safety and efficacy of the FasTracker 325 infusion catheter and Contour-PVA embolic particles used to perform UAE, which are the products of Boston Scientific (Natick, MA, USA).

"This effort is a landmark research project that should definitively demonstrate the value of this therapy as a preferred treatment option,” noted John C. Lipman, M.D., Piedmont Hospital (Atlanta, GA, USA), who treated the trial's first patient.



Related Links:
Boston Scientific